• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Advertisement

Ahmedabad Jan. 25 Torrent Pharmaceuticals Ltd, the Ahmedabad-based pharma major, has posted a consolidated profit after tax (PAT) of Rs 26 crore in the quarter ended December 31, 2006, up by more than 300 per cent from Rs 6 crore in the same period the year before.

Releasing its financial results for third quarter and nine months ended December 31, 2006, the company said here that the consolidated sales for nine months registered a growth of 27 per cent to touch Rs 955 crore (Rs 753 crore).

For the quarter ended December 2006, consolidated sales grew by 22 per cent, reaching Rs 334 crore as against Rs 273 crore for the comparable period. The profit before depreciation, interest and tax for the third quarter nearly doubled to Rs 40 crore (Rs 21 crore) riding on the back of profitability from India and Brazil businesses.

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
EID Parry Q3 net at Rs 3.53 cr

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line